Hasil Pencarian (2)
small molecule | CAS: 935283-04-8
Linzagolix is a non-peptide, selective antagonist of the gonadotropin-releasing hormone (GnRH) receptor. It has been studied for the treatment of estrogen-dependent conditions such as uterine fibroids and endometriosis.[A253642,A253647] It is similar to other…
Kategori:
Anti-Gonadotropin-Releasing HormonesBCRP/ABCG2 SubstratesCytochrome P-450 CYP2C8 Inhibitors
+18
Target Protein:
Gonadotropin-releasing hormone receptor
Waktu ParuhThe half-life of li…
Vol. DistribusiAfter seven days of…
KlirensThe geometric mean …
Genetik
-
small molecule | CAS: 737789-87-6
Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. It was first approved in Japan in 2019, under the brand name Relumina, for the symptomatic treatment of uterine fibroids,[…
Kategori:
AmidesAnti-Gonadotropin-Releasing HormonesAntiandrogens
+30
Target Protein:
Gonadotropin-releasing hormone receptor
Waktu ParuhThe average effecti…
Vol. Distribusi-
KlirensThe average renal c…
Genetik
-